• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Smart for Life Inc. (Amendment)

    2/12/24 10:06:22 AM ET
    $SMFL
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $SMFL alert in real time by email
    SC 13G/A 1 g084029_sch13ga.htm SC 13G/A

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G/A

     

    Under the Securities Exchange Act of 1934
    (Amendment No. 3)*

     

    SMART FOR LIFE, INC.

     

    (Name of Issuer)

     

    Common Stock, par value $0.0001 per share

     

    (Title of Class of Securities)

     

    83204U509

     

    (CUSIP Number)

     

    December 31, 2023

     

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)
    ☒ Rule 13d-1(c)
    ☐ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

    CUSIP No. 83204U509

      13G/A   Page 2 of 10 Pages
       

     1.

    NAMES OF REPORTING PERSONS

    Ionic Ventures, LLC
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    ☐
    (b)    ☒
    3. SEC USE ONLY
     
    4. CITIZENSHIP OR PLACE OF ORGANIZATION
     
    California, United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5. SOLE VOTING POWER
     
    0
    6.

    SHARED VOTING POWER

     

    203,268 (1)(2)

    7. SOLE DISPOSITIVE POWER
     
    0
    8.

    SHARED DISPOSITIVE POWER

     

    203,268 (1)(2)

    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    203,268 (1)(2)
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    ☐
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    9.9%(2)
    12. TYPE OF REPORTING PERSON (see instructions)

    OO

     

    (1)The number of shares of common stock, par value $0.0001 per share, of the issuer (the “Common Stock”), beneficially owned by the reporting persons disclosed in this Amendment No. 3 to Statement on Schedule 13G (this “Amendment”) reflects (i) the one-for-three reverse stock split of the Common Stock, effective August 2, 2023, and (ii) the subsequent one-for-three reverse stock split of Common Stock, effective October 27, 2023.
    (2)As more fully described in Item 4 of this Amendment, such shares and percentage do not give effect to the shares of Common Stock issuable upon full exercise of certain Common Stock purchase warrants, which exercises are subject to a 9.99% beneficial ownership blocker. and Series A purchase warrants owned by the reporting person, which exercises are subject to a 4.99% beneficial ownership blocker.

     

     

     

    CUSIP No. 83204U509    13G/A Page 3 of 10 Pages
     
    1. NAMES OF REPORTING PERSONS

    Ionic Management, LLC
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    ☐
    (b)    ☒
    3. SEC USE ONLY
     
    4. CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware, United States
             
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5. SOLE VOTING POWER
     
    0
    6.

    SHARED VOTING POWER

     

    203,268 (1)(2)

    7. SOLE DISPOSITIVE POWER
     
    0
    8.

    SHARED DISPOSITIVE POWER

     

    203,268 (1)(2)

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     

    203,268 (1)(2)

    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    ☐
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    9.9% (1)
    12. TYPE OF REPORTING PERSON (see instructions)

    OO

     

    (1)The number of shares of Common Stock beneficially owned by the reporting persons disclosed in this Amendment reflects (i) the one-for-three reverse stock split of the Common Stock, effective August 2, 2023, and (ii) the subsequent one-for-three reverse stock split of Common Stock, effective October 27, 2023.
    (2)As more fully described in Item 4 of this Amendment, such shares and percentage do not give effect to the shares of Common Stock issuable upon full exercise of certain Common Stock purchase warrants indirectly owned by the reporting person, which exercises are subject to a 9.99% beneficial ownership blocker, and Series A purchase warrants indirectly owned by the reporting person, which exercises are subject to a 4.99% beneficial ownership blocker.

     

     

     

    CUSIP No. 83204U509

      13G/A   Page 4 of 10 Pages
       
    1. NAMES OF REPORTING PERSONS

    Keith Coulston
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    ☐
    (b)    ☒
    3. SEC USE ONLY
     
    4. CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5. SOLE VOTING POWER
     
    0
    6.

    SHARED VOTING POWER

     

    203,268 (1)(2)

    7. SOLE DISPOSITIVE POWER
     
    0
    8.

    SHARED DISPOSITIVE POWER

     

    203,268 (1)(2)

    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    203,268 (1)(2)
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    ☐
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    9.9%(2)
    12. TYPE OF REPORTING PERSON (see instructions)

    IN

     

    (1)The number of shares of Common Stock beneficially owned by the reporting persons disclosed in this Amendment reflects (i) the one-for-three reverse stock split of the Common Stock, effective August 2, 2023, and (ii) the subsequent one-for-three reverse stock split of the Common Stock, effective October 27, 2023.
    (2)As more fully described in Item 4 of this Amendment, such shares and percentage do not give effect to the shares of Common Stock issuable upon full exercise of certain Common Stock purchase warrants indirectly owned by the reporting person, which exercises are subject to a 9.99% beneficial ownership blocker, and Series A purchase warrants indirectly owned by the reporting person, which exercises are subject to a 4.99% beneficial ownership blocker.

     

     

     

    CUSIP No. 83204U509

      13G/A   Page 5 of 10 Pages
       
    1. NAMES OF REPORTING PERSONS

    Brendan O’Neil
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a)    ☐
    (b)    ☒
    3. SEC USE ONLY
     
    4. CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5. SOLE VOTING POWER
     
    0
    6.

    SHARED VOTING POWER

     

    203,268 (1)(2)

    7. SOLE DISPOSITIVE POWER
     
    0
    8.

    SHARED DISPOSITIVE POWER

     

    203,268(1)(2)

    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    203,268(1)(2)
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions)    ☐
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    9.9%(2)
    12. TYPE OF REPORTING PERSON (see instructions)

    IN

     

    (1)The number of shares of Common Stock beneficially owned by the reporting persons disclosed in this Amendment reflects (i) the one-for-three reverse stock split of the Common Stock, effective August 2, 2023, and (ii) the subsequent one-for-three reverse stock split of the Common Stock, effective October 27, 2023.
    (2)As more fully described in Item 4 of this Amendment, such shares and percentage do not give effect to the shares of Common Stock issuable upon full exercise of certain Common Stock purchase warrants indirectly owned by the reporting person, which exercises are subject to a 9.99% beneficial ownership blocker, and Series A purchase warrants indirectly owned by the reporting person, which exercises are subject to a 4.99% beneficial ownership blocker.

     

     

     

    CUSIP No. 83204U509   13G/A   Page 6 of 10 Pages

     

    This Amendment No. 3 to Statement on Schedule 13G (“Amendment No. 3”) amends and supplements the Statement on Schedule 13G, filed by the reporting persons with the U.S. Securities and Exchange Commission (“SEC”) on December 21, 2022 (the “Schedule 13G”), as amended and supplemented by Amendment No. 1 to the Schedule 13G, filed by the reporting persons on February 13, 2023 (“Amendment No. 1”) and Amendment No. 2 to the Schedule 13G, filed by the reporting persons with the SEC on June 6, 2023 (“Amendment No. 2” and together with Amendment No. 1, the “Amendments”).

     

    The purpose of this Amendment No. 3 is to update the beneficial ownership information on the cover pages and in Item 4 in each of the Schedule 13G and the Amendments, as well as to amend Item 2(e) in each of the Schedule 13G and the Amendments.

     

    Item 1(a). Name of Issuer:

     

    Smart for Life, Inc. (the “Issuer”).

     

    Item 1(b). Address of Issuer’s Principal Executive Offices:

     

    The Issuer’s principal executive offices are located at 990 S Rogers Circle, Suite 3, Boca Raton, FL 33487.

     

    Item 2(a). Names of Persons Filing:

     

        (i) Ionic Ventures LLC, a California limited liability company (“Ionic”);
         
        (ii) Ionic Management, LLC, a Delaware limited liability company (“Ionic Management”);
         
        (iii) Keith Coulston (“Mr. Coulston”); and
         
        (iv) Brendan O’Neil (“Mr. O’Neil”).

     

    The foregoing persons are hereinafter collectively referred to as the “Reporting Persons”. Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.

     

    The Reporting Persons have entered into a Joint Filing Agreement, a copy of which was filed as Exhibit 1 to the Schedule 13G filed by the Reporting Persons with the SEC on December 21, 2022, pursuant to which such Reporting Persons have agreed to file this Amendment No. 3 and all subsequent amendments to the Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

     

    The filing of this Amendment No. 3 should not be construed in and of itself as an admission by the Reporting Person as to beneficial ownership of the shares of Common Stock reported herein.  

     

    Item 2(b). Address of Principal Business Office or, if none, Residence:

     

    The principal business address of each of the Reporting Persons is 3053 Fillmore Street, Suite 256, San Francisco, CA 94123.

     

    Item 2(c). Citizenship:

     

    Ionic is a limited liability company organized under the laws of the State of California. Ionic Management is a limited liability company organized under the laws of the State of Delaware. Each of Mr. Coulston and Mr. O’Neil is a citizen of the United States.

     

    Item 2(d). Title of Class of Securities:

     

    The title of the class of securities to which the Schedule 13G and this Amendment No. 3 relates is the Issuer’s common stock, par value $0.0001 per share (the “Common Stock”).

     

    Item 2(e). CUSIP Number: 83204U509 

     

     

     

    CUSIP No. 83204U509   13G/A   Page 7 of 10 Pages

     

    Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

     

    Not applicable.

     

    Item 4. Ownership.

     

    The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Amendment No. 3 and is incorporated herein by reference for each such Reporting Person. The ownership percentages reported are based on (i) 1,831,453 shares of Common Stock outstanding as of December 13, 2023, as reported in the Issuer’s Registration Statement on Form S-1, filed with the SEC on December 15, 2023, and (ii) 203,268 shares of Common Stock issuable upon exercise of (x) certain common stock purchase warrants held by Ionic, which further exercises thereof are subject to a 9.99% beneficial ownership blocker (the “Blocker”), and (y) certain Series A purchase warrants held by Ionic exercisable for up to 667 shares of Common Stock, which further exercises thereof are subject to a 4.99% beneficial ownership blocker ((x) and (y) together, the “Warrants”).

     

    Ionic holds the Warrants exercisable for up to an aggregate of 357,793 shares of Common Stock, of which 154,525 shares are not deemed beneficially owned by Ionic as a result of the triggering of the Blocker, which prohibits Ionic from exercising the Warrants if, as a result of such exercise, the holder, together with its affiliates and any persons acting as a group together with such holder or any of such affiliates, would beneficially own more than 4.99% or 9.99%, as applicable, of the total number of shares of Common Stock then issued and outstanding immediately after giving effect to such exercise.

     

    Ionic is the beneficial owner of 203,268 shares of Common Stock (the “Shares”). Ionic has the power to dispose of and the power to vote the Shares beneficially owned by it, which power may be exercised by its manager, Ionic Management. Each of the managers of Ionic Management, Mr. O’Neil and Mr. Coulston, has shared power to vote and/or dispose of the Shares beneficially owned by Ionic and Ionic Management. Neither Mr. O’Neil nor Mr. Coulston directly owns the Shares. By reason of the provisions of Rule 13d-3 of the Act, each of Mr. O’Neil and Mr. Coulston may be deemed to beneficially own the Shares which are beneficially owned by each of Ionic and Ionic Management, and Ionic Management may be deemed to beneficially own the Shares which are beneficially owned by Ionic.

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

     

     

    CUSIP No. 83204U509   13G/A   Page 8 of 10 Pages

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    Not applicable.

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9. Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10. Certification.

     

    By signing below each of the Reporting Persons certify that, to the best of each of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

    CUSIP No. 83204U509   13G/A   Page 9 of 10 Pages

     

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: February 12, 2024 IONIC VENTURES, LLC
       
      By: Ionic Management, LLC
             its Manager
       
      By: /s/ Keith Coulston
        Name: Keith Coulston
        Title: Manager
       
      IONIC MANAGEMENT, LLC
       
      By: /s/ Keith Coulston
        Name: Keith Coulston
        Title: Manager
         
      /s/ Brendan O’Neil
      Brendan O’Neil
         
      /s/ Keith Coulston
      Keith Coulston
         

     

     

     

    CUSIP No. 83204U509   13G/A   Page 10 of 10 Pages

     

     EXHIBIT 1

     

    JOINT FILING AGREEMENT

    PURSUANT TO RULE 13d-1(k)

     

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G/A is filed on behalf of each of the undersigned and that all subsequent amendments to the statement on Schedule 13G/A shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. The undersigned hereby further agree that this Joint Filing Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original, but all of which counterparts shall together constitute one and the same instrument.

     

    Date: February 12, 2024 IONIC VENTURES, LLC
       
      By: Ionic Management, LLC,
             its Manager
       
      By: /s/ Keith Coulston
        Name: Keith Coulston
        Title: Manager
       
      IONIC MANAGEMENT, LLC
       
      By: /s/ Keith Coulston
        Name: Keith Coulston
        Title: Manager
         
      /s/ Brendan  O’Neil
      Brendan O’Neil
         
      /s/ Keith Coulston
      Keith Coulston

     

     

    Get the next $SMFL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SMFL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SMFL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Smart for Life Reports Significant Balance Sheet Improvement; Achieves Over $9.4 Million in Positive Net Stockholders' Equity Following Successful Restructuring Efforts

      MIAMI, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (OTC:SMFL) ("Smart for Life" or the "Company"), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced significant progress in strengthening its balance sheet following a series of restructuring initiatives over the past several quarters. The Company has significantly improved its financial position, transitioning from negative net stockholders' equity to over $9.4 million in positive net stockholders' equity as of September 20, 2024. The Company also announced that it has successfully filed its 2023 annual report on Form 10-K

      9/23/24 5:54:48 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Smart for Life Provides Update Following Nasdaq Delisting Due to Audit Delays; Reports Plans to Reapply to Nasdaq Upon Full Compliance

      MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (OTC:SMFL) ("Smart for Life" or the "Company"), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today provided an update following its delisting from Nasdaq, which was primarily due to delays in the completion of its audit. The Company's common stock continues to be quoted on the OTC Markets, and the ticker symbol "SMFL" remains unchanged. Management believes this move to the OTC Markets is temporary and the Company plans to reapply for listing as soon as it is fully compliant with the listing requirements. "We are working diligently

      9/20/24 4:40:41 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Smart For Life Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference

      MIAMI, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced that Darren Minton, Chief Executive Officer of Smart For Life, will be participating at the H.C. Wainwright 26th Annual Global Investment Conference, which is being held September 9th - 11th, 2024 at the Lotte New York Palace Hotel in New York City. The H.C. Wainwright Global Investment Conference brings together companies, industry professionals and investors from various business sectors, including Heath & Wellness, for

      9/9/24 8:00:00 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    SEC Filings

    See more
    • SEC Form 25-NSE filed by Smart for Life Inc.

      25-NSE - SMART FOR LIFE, INC. (0001851860) (Subject)

      3/21/25 11:31:13 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Smart for Life Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - SMART FOR LIFE, INC. (0001851860) (Filer)

      12/13/24 5:00:10 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form NT 10-Q filed by Smart for Life Inc.

      NT 10-Q - SMART FOR LIFE, INC. (0001851860) (Filer)

      11/14/24 4:22:21 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Hrt Financial Lp sold $33,620 worth of Class A Shares (39,093 units at $0.86), decreasing direct ownership by 86% to 6,543 units (SEC Form 4)

      4 - SMART FOR LIFE, INC. (0001851860) (Issuer)

      9/12/24 11:55:41 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Large owner Hrt Financial Lp sold $30,996 worth of Class A Shares (29,802 units at $1.04) and bought $37,985 worth of Class A Shares (41,684 units at $0.91), increasing direct ownership by 35% to 45,636 units (SEC Form 4)

      4 - SMART FOR LIFE, INC. (0001851860) (Issuer)

      9/11/24 2:48:13 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • New insider Hrt Financial Lp claimed ownership of 33,754 units of Class A Shares (SEC Form 3)

      3 - SMART FOR LIFE, INC. (0001851860) (Issuer)

      9/11/24 2:34:56 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Smart for Life Inc.

      SC 13G/A - SMART FOR LIFE, INC. (0001851860) (Subject)

      11/14/24 6:49:12 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Smart for Life Inc. (Amendment)

      SC 13G/A - SMART FOR LIFE, INC. (0001851860) (Subject)

      2/12/24 10:06:22 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by Smart for Life Inc. (Amendment)

      SC 13G/A - SMART FOR LIFE, INC. (0001851860) (Subject)

      6/6/23 3:54:36 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Hrt Financial Lp sold $30,996 worth of Class A Shares (29,802 units at $1.04) and bought $37,985 worth of Class A Shares (41,684 units at $0.91), increasing direct ownership by 35% to 45,636 units (SEC Form 4)

      4 - SMART FOR LIFE, INC. (0001851860) (Issuer)

      9/11/24 2:48:13 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    Leadership Updates

    Live Leadership Updates

    See more
    • Smart for Life Announces Appointment of Jessica Walters as Chief Marketing Officer

      MIAMI, July 09, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced that it has appointed Jessica Walters as the Company's new Chief Marketing Officer. Ms. Walter's appointment as CMO is believed by management to position Smart for Life for long term growth and utilize the Company's IP from its acquisitions to increase sales opportunities across its portfolio. "Our appointment of Jessica Walters as CMO represents a strategic effort to broaden our reach and strengthen our position in the Health and Wellne

      7/9/24 8:30:00 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • ōku® and Inspired Specialty Products Inc. Appoint Consumer Industry Veteran Ryan F. Zackon as Co-Chair of the Board of Directors

      SOLANA BEACH, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Inspired Specialty Products Inc., creator of the popular ōku® Conscious EnergyTM gummy snacks, proudly announces the appointment of Ryan F. Zackon as co-chair of its Board of Directors. A seasoned leader in the consumer-packaged goods and health and wellness industries, Zackon joins co-chair Kenneth B. Hamlet, former CEO of Holiday Inns Inc. Hotel Group, then the largest hospitality and gaming company in the world, and Patti Larchet, former CEO of Jenny Craig International. "We are excited to welcome Ryan to our team" expressed Carolyn J. Hamlet, founder and CEO. "His proven expertise will be key to propelling ōku®'s strategic growth

      5/7/24 8:58:50 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Smart for Life Appoints Prominent Industry Executive David Trosin to Company's Advisory Board

      MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a global leader in the Health & Wellness sector marketing and manufacturing nutritional supplements and foods, announced today that it has appointed David Trosin, the Managing Director of Health Sciences Certification at NSF International, to the Company's advisory board. "David Trosin joins Smart for Life with decades of industry experience, and a career providing certification and risk management solutions to international clients, retailers and professional sporting organizations around the world," said Darren Minton, CEO of Smart for Life. "We are excited to have David joi

      4/24/24 8:30:00 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SMFL
    Financials

    Live finance-specific insights

    See more
    • Smart for Life Announces Q2 2022 Financial Results

      Revenue Increases 401.2% Year-Over-Year to $4.3 Million for the Second Quarter of 2022 Due to Successful Acquisition Strategy Gross Profit Margin Increases to 41.6% Versus 1.1% for the Same Period Last Year MIAMI, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, today provided a business update and reported financial results for the second quarter ended June 30, 2022. "We continue to generate solid year-over-year growth with revenues increasing more than four-fold to $4.3 million for the second quar

      8/15/22 4:30:00 PM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • REMINDER: Smart for Life to Host a Conference Call Today to Discuss Ceautamed Worldwide Acquisition, Positive Developments, and New Strategic Initiatives

      MIAMI, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, reminds investors that it will host a conference call today, Wednesday, August 10, 2022, at 4:15 P.M. Eastern Time (ET) to discuss the Ceautamed Worldwide acquisition, positive developments, and new strategic initiatives. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 354190. A webcast of the call may be accessed at htt

      8/10/22 9:15:00 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Smart for Life to Host a Conference Call to Discuss Ceautamed Worldwide Acquisition, Positive Developments, and New Strategic Initiatives

      MIAMI, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (NASDAQ:SMFL) ("Smart for Life" or the "Company"), a high growth global leader in the health & wellness sector, marketing and manufacturing nutritional foods and supplements worldwide, today announced it will host a conference call on Wednesday, August 10, 2022, at 4:15 P.M. Eastern Time (ET) to discuss the Ceautamed Worldwide acquisition, positive developments, and new strategic initiatives. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 354190. A webcast of the call may be accessed at https://www.we

      8/8/22 9:15:00 AM ET
      $SMFL
      Medicinal Chemicals and Botanical Products
      Health Care